PEN

• 2026-05-07 merger or acquisition eventrecentOpen filing ↗
  “…provided to the Company's stockholders, received the following votes; however, because the Merger Proposal was approved, the…”
  +1 more passage from the same document

  • “…more detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 1,…”
• 2026-05-06 capital return (buybacks/dividends)recentOpen filing ↗
  “…elect to secure additional financing as we continue to execute our business strategy. If we require or elect to raise additional…”
  +1 more passage from the same document

  • “…we require or elect to raise additional funds, we may do so through equity or debt financing, which may not be available on…”
• 2026-05-06 merger or acquisition eventrecentOpen filing ↗
  “…vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. The Company…”
  +1 more passage from the same document

  • “…centers on removing blood clots from head-to-toe with speed, safety and simplicity. The Company focuses on developing, manufacturing…”
• 2026-02-25 capital return (buybacks/dividends)recentOpen filing ↗
  “…In such case, a valuation allowance to reduce our DTAs may be required, which would materially increase our tax expense in the…”
  +1 more passage from the same document

  • “…increase our tax expense in the period the valuation allowance is recorded and could have a material adverse impact on our…”
• 2026-02-25 merger or acquisition eventrecentOpen filing ↗
  “…In addition, during the year ended December 31, 2024, we permanently ceased sales of our immersive healthcare products and related…”
  +1 more passage from the same document

  • “…vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. The Company…”

Recorded SEC filings in plain language — not advice or a prediction.